SOTYKTU Trademark

Trademark Overview

On Monday, August 22, 2022, a trademark application was filed for SOTYKTU with the United States Patent and Trademark Office. The USPTO has given the SOTYKTU trademark a serial number of 97558218. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, March 18, 2024. This trademark is owned by Bristol-Myers Squibb Company. The SOTYKTU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of auto-immune diseases, including psoriasis and psoriatic arthritis
sotyktu

General Information

Serial Number97558218
Word MarkSOTYKTU
Filing DateMonday, August 22, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements

Description of MarkThe mark consists of the word "SOTYKTU" with a stylized circle design to the right.
Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of auto-immune diseases, including psoriasis and psoriatic arthritis
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, September 11, 2022
Primary Code005
First Use Anywhere DateWednesday, September 14, 2022
First Use In Commerce DateWednesday, September 14, 2022

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Tuesday, March 19, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 18, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 21, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Sunday, February 18, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 25, 2024USE AMENDMENT FILED
Sunday, February 18, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 25, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 23, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 23, 2023NON-FINAL ACTION E-MAILED
Thursday, February 23, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 14, 2023ASSIGNED TO EXAMINER
Tuesday, September 13, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, September 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 25, 2022NEW APPLICATION ENTERED

Related Keywords

sotyktu including diseases psoriasis psoriatic arthritis immune auto preparations human treatment